| Serial Number | 79314148 |
| Word Mark | H.F.M BY TICEBA |
| Filing Date | Saturday, April 10, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, January 24, 2023 |
| Registration Number | 6959288 |
| Registration Date | Tuesday, January 24, 2023 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, November 8, 2022 |
| Description of Mark | The mark consists of the wording "H.F.M.", underlined and above the wording "BY TICEBA", all in the color blue. The wording is surrounded by 8 rods having a small ball at each end and alternating in color, with every other one in the color blue and the others in the color green. The color white represents background, outlining, shading, and/or transparent area and is not part of the mark. |
| Goods and Services | Pharmaceutical drugs, namely, pharmaceutical drugs for treatment of skin diseases, antibiotics, immune suppressants, anti-inflammatory pharmaceuticals; Pharmaceutical drugs for treatment of disease and disorders of the respiratory system, the gastrointestinal system, the endocrine system, the cardiovascular system, the nervous system, the musculoskeletal system, the urinary system, the integumentary system, the reproductive system, for the treatment of blood diseases and disorders; Pharmaceutical and veterinary preparations for treatment of vertigo, migraine, nausea, vomiting, for treatment of skin diseases, wound healing; Pharmaceutical preparations for anti-aging; Diagnostic agents for medical use; Preparations for medical purposes, namely, for the treatment of skin diseases; Substances for medical use, namely, for regeneration of tissue and anti-inflammation; Stem cells for medical purposes; Stem cells for veterinary purposes; Stem cells for aesthetic purposes, namely, for anti-aging, for use in dermatology procedures; Somatic stem cell therapeutics, namely, for medical therapeutic use; Fibroblasts for medical use; Fibroblasts for aesthetic purposes, namely, for use in dermatology procedures; Pharmaceutical implants, namely, implantable surgery bones, bone grafts, cells, bone marrow; Surgical implants derived from stem cells, namely, surgical implants derived from living tissues and living stem cells; Surgical implants derived from fibroblasts, namely, surgical implants comprised of living fibroblasts tissue cells; Biological tissue for implantation, namely, implants comprising living tissues; Cell growth media for growing cells for medical use; Pharmaceutical preparations for tissue regeneration; Vascular grafts; Living tissue, namely, surgical implants comprised of living tissues; Biotechnologically engineered tissue products, namely, cell sheets/plasters for wound healing/burns, eye lense grafts, bone grafts, biological tissue grafts, human allograft tissue |
| Indication of Colors claimed | The color(s) blue and green is/are claimed as a feature of the mark. |
| Goods and Services | Stem cells for scientific or research use; cell growth media for growing cells for scientific use |
| Goods and Services | Medical services relating to the removal, treatment, processing and preservation of medical cells and human tissue, stem cells and bone marrow, also in the field of regenerative medicine, including tissue engineering; medical services in connection with the removal, treatment and processing of human tissue and stem cells, human tissue and stem cell bank services, including in the field of regenerative medicine, including tissue engineering; medical services relating to the cultivation and extraction of stem cells; medical services in connection with the cultivation and extraction of stem cells |
| Goods and Services | Stem cell research; scientific research and development and medical research and development in the field of stem cells; Scientific research, testing and analysis services in the field of regenerative medicine and tissue engineering; Scientific research for medical purposes; Medical research; Research and development of new products for others; Consultancy in the field of pharmaceutical research; Providing information on medical and scientific research on pharmaceutical products; Biomedical research; Preparation of reports relating to scientific research, namely, technical writing for others; Research in the field of biotechnology; Research in the field of gene therapy; Research and development in the field of immunology; Research and development in the field of antibodies; Research and development in the field of antibody technology; Research and development in the field of bacteriology; Research and development in the field of gene expression systems; Research and development in the field of vaccines; Research and development services for the pharmaceutical industry; Research and development services in the field of biotechnology; Development of industrial processes, namely, engineering of industrial processes to manufacture stem cells; Development of industrial processes, namely, in the field of regenerative medicine and tissue engineering;Industrial process research in the field of regenerative medicine, tissue engineering, chemical engineering |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 28, 2021 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 28, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 28, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 28, 2021 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | NOT AVAILABLE |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 01 - Individual |
| Address | DE |
| Party Name | NOT AVAILABLE |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 01 - Individual |
| Address | DE |
| Party Name | NOT AVAILABLE |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 01 - Individual |
| Address | DE |
| Event Date | Event Description |
| Tuesday, May 23, 2023 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Monday, May 1, 2023 | FINAL DISPOSITION NOTICE SENT TO IB |
| Monday, May 1, 2023 | FINAL DISPOSITION PROCESSED |
| Monday, April 24, 2023 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, January 24, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, January 24, 2023 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, December 20, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Wednesday, November 30, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, November 30, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Tuesday, November 8, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, November 8, 2022 | PUBLISHED FOR OPPOSITION |
| Monday, November 7, 2022 | NOTIFICATION PROCESSED BY IB |
| Wednesday, October 19, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, October 19, 2022 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, October 19, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, September 29, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, September 29, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, September 29, 2022 | NON-FINAL ACTION E-MAILED |
| Thursday, September 29, 2022 | NON-FINAL ACTION WRITTEN |
| Tuesday, August 9, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, August 9, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, August 9, 2022 | ASSIGNED TO LIE |
| Wednesday, July 13, 2022 | NOTICE OF REVIVAL - E-MAILED |
| Wednesday, July 13, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, July 13, 2022 | PETITION TO REVIVE-GRANTED |
| Wednesday, July 13, 2022 | TEAS PETITION TO REVIVE RECEIVED |
| Wednesday, July 13, 2022 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Wednesday, July 13, 2022 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Saturday, January 15, 2022 | REFUSAL PROCESSED BY IB |
| Tuesday, December 28, 2021 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Tuesday, December 28, 2021 | REFUSAL PROCESSED BY MPU |
| Thursday, December 2, 2021 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Wednesday, December 1, 2021 | NON-FINAL ACTION WRITTEN |
| Tuesday, November 30, 2021 | ASSIGNED TO EXAMINER |
| Friday, July 2, 2021 | APPLICATION FILING RECEIPT MAILED |
| Monday, June 28, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, June 25, 2021 | SN ASSIGNED FOR SECT 66A APPL FROM IB |